A planning committee of the National Academies of Sciences, Engineering, and Medicine will organize a public workshop featuring invited presentations and discussions to explore the relationship between medications and obesity, including medications that are used to treat obesity. The workshop will include presentations and discussions on the state of the science around the safety and efficacy of medications in people with overweight or obesity; medications that may cause changes in body composition and weight status; and medications used to treat obesity and obesity-related comorbidities. With a lens on diverse lived experiences and attention to weight bias and stigma, the workshop will also address the implications of pharmacotherapy for obesity on policy and legislation, economics, access, public perception and discourse, and population health.
The planning committee will organize the workshop, select and invite speakers and discussants, and moderate the discussions. A proceedings-in-brief and a full proceedings of the workshop will be prepared by a designated rapporteur in accordance with institutional guidelines.